GATA-3 expression is not associated with complete pathological response in triple negative breast cancer patients treated with neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

GATA-3 expression is not associated with complete pathological response in triple negative breast cancer patients treated with neoadjuvant chemotherapy

Published:2016-06 Issue:6 Volume:212 Page:539-544
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Wasserman Jason K.,Williams Phillip A.,Islam Shahidul,Robertson Susan J.

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference29 articles.

1. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin. Cancer Res.,2007

2. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer;Berry;JAMA,2006

3. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes;Carey;Clin. Cancer Res.,2007

4. Breast cancer molecular subtypes respond differently to preoperative chemotherapy;Rouzier;Clin. Cancer Res.,2005

5. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation;Asselin-Labat;Nat. Cell Biol.,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers;Life;2023-02-02

2. Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients;The Journal of Molecular Diagnostics;2021-10

3. Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer;Cancers;2021-04-01

4. Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer;Annals of Diagnostic Pathology;2020-12